Trials / Completed
CompletedNCT04024527
High Dose of Dual Therapy Plus Metronidazole for Helicobacter Pylori RescueTreatment
Efficacy of High Dose of Dual Therapy Plus Metronidazole for Helicobacter Pylori Rescue Treatment: A Randomized Clinical Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 306 (actual)
- Sponsor
- Shanghai Jiao Tong University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Dual therapy containing high dose of proton pump inhibitor (PPI) and amoxicillin had showed excellent eradication results with Helicobacter pylori first-line treatment. However, no study has examined the the efficacy of high dose of dual therapy or dual therapy plus metronidazole for H. pylori rescue treatment.This study is designed to evaluate the efficacy and safety of the addition of metronidazole to high dose of dual therapy for H. pylori rescue treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Esomeprazole | Proton pump inhibitor |
| DRUG | Amoxicillin | Antibiotic for H. pylori eradication |
| DRUG | Metronidazole | Antibiotic for H. pylori eradication |
Timeline
- Start date
- 2019-07-25
- Primary completion
- 2021-04-12
- Completion
- 2021-05-24
- First posted
- 2019-07-18
- Last updated
- 2021-09-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04024527. Inclusion in this directory is not an endorsement.